Los Angeles Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $776K | Sell |
69,083
-36,855
| -35% | -$414K | ﹤0.01% | 722 |
|
|
2025
Q1 | $484K | Sell |
105,938
-125,185
| -54% | -$572K | ﹤0.01% | 751 |
|
|
2024
Q4 | $1.3M | Sell |
231,123
-31,270
| -12% | -$176K | 0.01% | 547 |
|
|
2024
Q3 | $1.27M | Buy |
262,393
+19,925
| +8% | +$96.4K | 0.01% | 568 |
|
|
2024
Q2 | $1.18M | Buy |
+242,468
| New | +$1.18M | ﹤0.01% | 603 |
|
|
2022
Q2 | – | Sell |
-16,685
| Closed | -$381K | – | 1473 |
|
|
2022
Q1 | $381K | Buy |
+16,685
| New | +$381K | ﹤0.01% | 1144 |
|